Predictive markers of response to neoadjuvant therapy in rectal cancer

Journal of Surgical Research

Volumn 194, Issue 1, 2015, Pages 120-126

  García Flórez, Luis Joaquín ^a   Gómez Álvarez, Guillermo ^b   Frunza, Ana Madalina ^b   Barneo Serra, Luis ^c   Martínez Alonso, Carmen ^b   Fresno Forcelledo, Manuel Florentino ^b  

^a HOSPITAL SAN AGUSTÍN   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

Chemoradiotherapy; Neoadjuvant therapy; Predictive biomarkers; Rectal cancer

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA CATENIN; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; KI 67 ANTIGEN; PARAFFIN; PROTEIN BCL 2; PROTEIN P53; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; B CELL LYMPHOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECTUM CANCER; SCORING SYSTEM; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR DIFFERENTIATION; ADJUVANT THERAPY; CANCER STAGING; MIDDLE AGED; PATHOLOGY; RECTAL NEOPLASMS; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-BCL-2; RECTAL NEOPLASMS;

EID: 84924703354     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.10.005     Document Type: Article

References (39)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Eng J Med 351 2004 1731
2. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Eng J Med 355 2006 1114
3. S.A. Milgrom, and J. García-Aguilar Molecular biomarkers as predictors of response to neoadjuvant chemoradiation therapy in rectal cancer Semin Colon Rectal Surg 24 2013 119
4. J.M. Wheeler, E. Dodds, and B.F. Warren Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade Dis Colon Rectum 47 2004 2025
5. E.C. Zeestraten, P.J. Kuppen, C.J. van de Velde, and C.A. Marijnen Prediction in rectal cancer Semin Radiat Oncol 22 2012 175 Review
6. th ed. 2002 Willey-Liss New York
7. A. Mandard, F. Dalibard, and J. Mandard Pathological assessment of tumour regression after preoperative chemo/radiotherapy for esophageal carcinoma. Clinicopathologic correlations Cancer 73 1994 2680
8. P. Quirke, R. Steele, and J. Monson Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial Lancet 373 2009 821
9. R.J. Heald, and N.D. Karanjia Results of radical surgery for rectal cancer World J Surg 16 1992 848
10. F.G. Taylor, P. Quirke, and R.J. Heald Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study Ann Surg 253 2011 711
11. C. Rodel, P. Marthus, and T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688
12. A. Habr-Gama, J. Sabbaga, and J. Gama-Rodrigues Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum 56 2013 1109
13. M.G. Tytherleigh, V.V. Ng, A.A. Pitthankal, M.J. Wilson, and R. Farouk Preoperative staging of rectal cancer by magnetic resonance imaging remains an imprecise tool ANZ J Surg 78 2008 194
14. F.M. Smith, D. Waldron, and D.C. Winter Rectum-conserving surgery in the era of chemoradiotherapy Br J Surg 97 2010 1752
15. J. García-Aguilar, Z. Chen, and D.D. Smith Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer Ann Surg 254 2011 486
16. J.W. Huh, H.R. Kim, and Y.J. Kim Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer Dis Colon Rectum 56 2013 698
17. H. Qiu, P. Sirivongs, D.A. Rothenberger, and J. Garcia-Aguilar Molecular prognostic factors in rectal cancer treated by radiation and surgery Dis Colon Rectum 43 2000 451
18. P. Das, J.M. Skibber, and M.A. Rodriguez-Bigas Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer Cancer 109 2007 1750
19. R. Farkas, E. Pozsgai, and A.V. Schally Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer J Cancer Res Clin Oncol 138 2012 387
20. M.F. Kalady, L.F. de Campos-Lobato, and L. Stocchi Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer Ann Surg 250 2009 582
21. C. Molinari, M. Ballardini, and N. Teodorani Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study Radiat Oncol 6 2011 161
22. N. Guedj, F. Bretagnol, and P.E. Rautou Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas Hum Pathol 42 2011 1702
23. C. Ratto, R. Ricci, and V. Valentini Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: clinical and prognostic implications Ann Surg Oncol 14 2007 853
24. H. Bouzourene, F.T. Bosman, W. Seelentag, M. Matter, and P. Coucke Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy Cancer 94 2002 1121
25. C. Berger, A. de Muret, and P. Garaud Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications Int J Radiat Oncol Phys 37 1997 619
26. T. Suzuki, S. Sadahiro, and M. Fukasawa Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer Jpn J Clin Oncol 34 2004 740
27. B. Farnault, L. Moureau-Zabotto, and C. de Chaisemartin Facteurs prédictifs de réponse à la radiochimiothérapie néoadjuvante dans les cancers localement évolués et correlation de ces facteurs avec la survie Cancer Radiother 15 2011 279
28. V. Moreno García, P. Cejas, and M. Blanco Codesido Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy Int J Colorectal Dis 24 2009 741
29. U. Wallin, D. Rothenberger, A. Lowry, R. Luepker, and A. Mellgren CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer Dis Colon Rectum 56 2013 859
30. B.M. Ghadimi, M. Grade, and M.J. Difilippantonio Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy J Clin Oncol 23 2005 1826
31. R. Seicean, D. Crisan, and J.E. Boers The prognostic role of apoptosis mediators in rectal adenocarcinoma Hepatogastroenterology 58 2011 1490
32. M. Kudrimoti, E.Y. Lee, Y. Kang, M. Ahmed, and M. Mohiuddin Genetic markers predictive of response to induction chemoradiotherapy for locally advanced rectal cancers J Ky Med Assoc 105 2007 18
33. S. Rantanen, O. Monni, H. Joensuu, K. Franssila, and S. Knuutila Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma Leuk Limphoma 42 2001 1089
34. O. Schwander, T.H. Schiedeck, and H.P. Bruch P53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer Eur J Cancer 36 2000 348
35. T. Rich, F. Sinicrope, and C. Stephens Downstaging of T3 rectal cancer after preoperative infusional chemoradiation is correlated with spontaneous apoptosis index and BCL-2 staining Int J Radiat Oncol Biol Phys 36 Suppl 1 1996
36. F.M. Smith, J.V. Reynolds, N. Miller, R.B. Stephens, and M.J. Kennedy Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy Eur J Surg Oncol 32 2006 55
37. Y. Edden, S.D. Wexner, and M. Berho The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma Colorectal Dis 14 2012 555
38. N. Shinoura, Y. Yoshida, and M. Nishimura Expression level of Bcl-2 determines anti or proapoptotic function Cancer Res 59 1999 4119
39. T. Miyashita, S. Kitada, S. Krajewski, W.A. Horne, D. Delia, and J.C. Reed Overexpression of the Bcl-2 protein increases the half-life of p21Bax J Biol Chem 270 1995 26049